Wealthsource Partners, LLC Vbi Vaccines Inc Transaction History

Wealthsource Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.64 $898 - $1,984	-3,100 Reduced 3.26%	92,000 $27,000
Q4 2022 Feb 09, 2023	SELL	$0.38 - $22.5 $2,660 - $157,500	-7,000 Reduced 6.86%	95,100 $37,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $1,825 - $58,500	-2,500 Reduced 2.39%	102,100 $72,000
Q2 2022 Aug 10, 2022	SELL	$0.66 - $1.81 $25,674 - $70,409	-38,900 Reduced 27.11%	104,600 $85,000
Q1 2022 May 09, 2022	BUY	$1.27 - $2.47 $182,245 - $354,445	143,500 New	143,500 $238,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthsource Partners, LLC with notifications on news.